期刊文献+

西咪替丁伍用弓形虫ROP2蛋白免疫小鼠诱导免疫反应的初步研究 被引量:8

Study on Immune Response in BALB/c Mice Induced by ROP2 Protein of Toxoplasma gondii with Cimetidine
下载PDF
导出
摘要 目的观察西咪替丁伍用弓形虫棒状体蛋白2(ROP2)免疫小鼠诱导的免疫反应。方法 80只BALB/c小鼠随机分为A组、B组、C组和D组,各组分别经皮下注射PBS、弓形虫ROP2蛋白+PBS、弓形虫ROP2蛋白+福氏佐剂和弓形虫ROP2蛋白+西咪替丁[200 mg/(kg.d)]免疫BALB/c小鼠,每次ROP2蛋白免疫剂量为100μg/只(200μl),共免疫3次,每次间隔2周。于首次免疫前和每次免疫后2周,采血分离血清。末次免疫后2周,每组小鼠随机处死8只,无菌分离脾细胞,CCK-8法测定淋巴细胞增殖活性。流式细胞术检测小鼠全血T细胞亚群。ELISA法检测小鼠血清IgG抗体和γ干扰素(IFN-γ)水平。各组剩余12只小鼠经腹腔感染弓形虫RH株速殖子(5×104个/鼠),观察攻击感染后小鼠生存时间。结果末次免疫后2周,A、B、C和D组小鼠的血清IFN-γ水平分别为(659.750±239.962)、(872.750±197.011)、(1 600.750±480.680)和(1 494.375±451.655)pg/ml,血清特异性IgG抗体水平分别为0.504±0.078、0.592±0.160、1.068±0.111和1.046±0.147,脾细胞增殖活性分别为0.504±0.078、0.592±0.160、0.831±0.130和0.762±0.089,外周血CD4+/CD8+比值分别为0.504±0.078、0.592±0.160、0.831±0.130和0.762±0.089,C和D组均显著高于A和B组(前3个指标,均P<0.01;后者,均P<0.05),D组与C组的差异均无统计学意义(P>0.05)。各免疫组弓形虫攻击感染后,A、B、C和D组小鼠的生存时间中位数分别为96、108、132和132 h,C组和D组小鼠平均存活时间显著长于A组和B组(P<0.05),D组与C组的相比,差异无统计学意义(P>0.05)。结论西咪替丁可增强ROP2蛋白诱导的细胞免疫和体液免疫反应。 Objective To observe the immune response induced by ROP2 protein of Toxoplasma gonddi with cimetidine in mice. Methods Eighty BALB/c mice were randomly divided into 4 groups: PBS(group A), ROP2 protein (group B), ROP2 protein-Freund’s adjuvant (group C) and ROP2 protein-cimetidine(group D). Mice were immunized with PBS, ROP2 protein, ROP2 protein and Freund’s adjuvant, ROP2 protein and cimetidine[200 mg/(kg·d)] by subcutaneous injection three times at an interval of 2 weeks, respectively. Experimental mice were immunized with 100 μg ROP2 proteins, which were diluted to a final volume of 200 μl in PBS. On day 13, 27 and 41 after immunization, mice sera were collected for determination of antibody IgG and cytokine IFN-γ by ELISA. Two weeks after the final immuni-zation, T cells subpopulation was detected by flow cytometry and splenocyte proliferation activity was determined with CCK-8. Another 12 immunized mice in each group were intraperitoneally challenged with 5×104 tachyzoites of T. gondii and the survival time was observed. Results Two weeks after final immunization, compared with groups A[(659.750±239.962) pg/ml] and B [(872.750±197.011) pg/ml], the level of IFN-γ significantly increased in groups C [(1 600.750±480.680) pg/ml] and D [(1 494.375±451.655) pg/ml] (P〈0.01). Similarly, compared with groups A (0.636±0.108) and B (0.871±0.089), the level of IgG was also higher in groups C(1.068±0.111) and D(1.046±0.147) (P〈0.01). The proliferation of splenocytes rose in group C(0.831±0.130) after immunization, and similarly in group D (0.762±0.089), and were both significantly higher than that of groups A (0.504±0.078) and B (0.592±0.160)(P〈0.01). Moreover, ratio of CD4+/CD8+ in groups C (0.831±0.130) and D (0.762±0.089) were higher than that of groups A(0.504±0.078) and B(0.592±0.160)(P〈0.05). After challenge with violent virulence strain of tachyzoites, the median survival time of mice in groups A, B, C, and D were 96, 108, 132, and 132 h, respectively. The mean survival time of mice in groups C and D were longer than that of groups A and B(P〈0.05). There was no significant difference in 5 parameters between C and D: the level of IFN-γ and IgG, CD4+/CD8+ ratio, splenocyte proliferation, and survival time of mice(P〉0.05). Conclusion Cimetidine can enhance the humoral and cellular immune response induced by ROP2 protein.
出处 《中国寄生虫学与寄生虫病杂志》 CAS CSCD 北大核心 2013年第2期99-103,共5页 Chinese Journal of Parasitology and Parasitic Diseases
基金 国家重点基础研究发展规划项目(973计划)(No.2010CB530001) 安徽省教育厅重点资助项目(No.KJ2012A201)~~
关键词 刚地弓形虫 西咪替丁 棒状体蛋白2 免疫反应 蛋白疫苗 Toxoplasma gondii;Cimetidine Rhpotry protein 2;Immune response;Protein vaccine
  • 相关文献

参考文献21

  • 1Sahasrabudhe DM, McCune CS, O'Donnell RW, et al. Inhibi- tion of suppressor T lymphocytes (Ts) by cimetidine [J]. J Imrrmnol, 1987, 138(9): 2760-2763.
  • 2Brockmeyer NH, Kreuzfelder E, Guttmann W, et al. Cimetidine and the immuno-response in healthy volunteers[J]. J Invest Der- matol, 1989, 93(6): 757-761.
  • 3Ershler WB, Hacker MP, Burroughs BJ, et al. Cimetidine and the immune response I. In vivo augmentation of nonspecific and spe- cific immune response [J]. Clin Immnnol Immnnopathol, 1983, 26(1): 10-17.
  • 4Bradley PJ, Ward C, Cheng SJ, et al. Proteomic analysis of rhop- try organelles reveals many novel constituents for host-parasite interactions in Toxoplasma gondii [J]. J Biol Chem, 2005, 280 (40) : 34245-34258.
  • 5Leyva R, Herion P, Saavedra R. Genetic immunization with plas- mid DNA coding for the ROP2 protein of Toxoplasma gondii [J]. Parasitol Res, 2001, 87(1): 70-79.
  • 6Roque-Resendiz JL, Rosales R, Herion P. MVA ROP2 vaccinia virus recombinant as a vaccine candidate for toxoplasmosis [J]. Parasitology, 2004, 128(Pt4): 397-405.
  • 7Ismael AB, Sekkai D, Collin C, et al. The MIC3 gene of Tox- oplasma gondii is a novel potent vaccine candidate against toxo- plasmosis [J ]. Infect Immun, 2003, 71 ( 11 ) : 6222-6228.
  • 8魏庆宽,李瑾,傅婷霞,柏雪莲,崔勇,张佃波,王洪法,刘玉冰,付斌,宰德福,黄炳成,刘克义,韩广东.弓形虫ROP2核酸疫苗免疫保护作用的研究[J].中国寄生虫学与寄生虫病杂志,2006,24(5):337-341. 被引量:22
  • 9魏庆宽.弓形虫多基因核酸疫苗构建及其免疫保护性研究[J].中国血吸虫病防治杂志,2012,24(2):173-177. 被引量:7
  • 10李文姝,谢自新,陈庆新,陈韶,张丽芳.弓形虫ROP2-SAG1重组复合蛋白及其重组质粒的免疫效应[J].中国寄生虫学与寄生虫病杂志,2010,28(5):359-363. 被引量:5

二级参考文献60

共引文献38

同被引文献105

引证文献8

二级引证文献45

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部